FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Angel One and Choice Equity Broking Pvt Ltd have given "Apply" recommendation to Star Health IPO. Axis Capital, B & K Securities India Private Ltd., Capital Market, Haitong Securities Private Limited, ICICI Securities, JM Financial Institutional Securities and Religare Broking Limited have "Neutral" view about the IPO. Dilip Davda, Marwadi Shares and Finance Ltd and InvestorGain.com recommend to "Avoid" the IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 2 | 0 | 7 | 3 | 0 |
% | 16.67 | 0.00 | 58.33 | 25.00 | 0.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Angel One | Apply | |
Axis Capital | Neutral | |
B & K Securities India Private Ltd. | Neutral | |
Capital Market | Neutral | |
Choice Equity Broking Pvt Ltd | Apply | |
Dilip Davda | Avoid | |
Haitong Securities Private Limited | Neutral | |
ICICI Securities | Neutral | |
JM Financial Institutional Securities | Neutral | |
Marwadi Shares and Finance Ltd | Avoid | |
Religare Broking Limited | Neutral | |
InvestorGain.com | Avoid |
The Captial Market (CapitalMarket.com) rating for Star Health IPO is 43. Their analysis recommends Avoid, however active risk seekers can try for the IPO.
Reviewer | Rating Score | Rating |
---|---|---|
Capital Market | 43 | Avoid, however active risk seekers can try |
[Dilip Davda] The company has suffered a severe setback for the last 18 months working and based on its negative earnings, the issue appears aggressively priced. Its P/E cannot be ascertained due to negative EPS for the last one and half yearsââ‚-â„¢ financial data. Investors should not get carried away due to the 10% quota for the Retail investors. There is no harm in ignoring this issue. You may get a chance to buy at discount post listing. Read detail review...
Post Recommendation Manage Recommendations
Note:
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|